Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-09-034089
Filing Date
2009-08-12
Accepted
2009-08-12 17:00:17
Documents
7
Period of Report
2009-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q c89000e10vq.htm 10-Q 906398
2 EXHIBIT 10.1 c89000exv10w1.htm EX-10.1 397156
3 EXHIBIT 10.2 c89000exv10w2.htm EX-10.2 195111
4 EXHIBIT 31.1 c89000exv31w1.htm EX-31.1 5917
5 EXHIBIT 31.2 c89000exv31w2.htm EX-31.2 5935
6 EXHIBIT 32.1 c89000exv32w1.htm EX-32.1 3434
7 EXHIBIT 32.2 c89000exv32w2.htm EX-32.2 3480
  Complete submission text file 0000950123-09-034089.txt   1519161
Mailing Address 2500 WILCREST 5TH FLOOR HOUSTON TX 77042
Business Address 2500 WILCREST 5TH FLOOR HOUSTON TX 77042 713-780-4754
ISOLAGEN INC (Filer) CIK: 0000357097 (see all company filings)

EIN.: 870458888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31564 | Film No.: 091007522
SIC: 2834 Pharmaceutical Preparations